Episode Details

In this episode of The Watchlist, listeners hear from Kim Thompson, CEO of Kraig Biocraft Laboratories (OTCQB: KBLB), as the company moves toward commercial-scale production of recombinant spider silk.

Kraig Biocraft Laboratories is positioning itself at the forefront of advanced materials, using genetically engineered silkworms to produce spider silk with unique strength and flexibility characteristics. The conversation explores how the company is transitioning from years of R&D into industrial-scale output, targeting 10 metric tons annually in the near term.

This episode covers:

• The science behind recombinant spider silk production
• Why spider silk is considered a high-performance material
• Kraig’s competitive positioning and intellectual property
• Progress toward commercial-scale manufacturing
• Key milestones expected in 2026

Website: https://www.kraiglabs.com

Disclaimer:
This podcast is made in partnership with Kraig Biocraft Laboratories. This content is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.